Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

Couturaud F, Pernod G, Presles E, Duhamel E, Jego P, Provost K, Pan-Petesch B, Bal Dit Sollier C, Tromeur C, Hoffman C, Bressollette L, Lorillon P, Girard P, Le Moigne E, Le Hir A, Guégan M, Laporte S, Mismetti P, Lacut K, Bosson JL, Bertoletti L, Sanchez O, Meyer G, Leroyer C, Mottier D.

Haematologica. 2019 Jan 3. pii: haematol.2018.210971. doi: 10.3324/haematol.2018.210971. [Epub ahead of print]

2.

A novel experimental thrombotic myocardial infarction and primary angioplasty model in swine.

Sideris G, Magkoutis N, Voicu S, Kang C, Bonneau M, Yannopoulos D, Bal Dit Sollier C, Dillinger JG, Berge N, Brouland JP, Henry P, Drouet L.

EuroIntervention. 2019 Apr 5;14(18):e1843-e1851. doi: 10.4244/EIJ-D-17-00763.

3.

[Involvement of thrombophilia in coronary thrombosis].

Bal Dit Sollier C, Drouet L.

Ann Cardiol Angeiol (Paris). 2017 Dec;66(6):365-372. doi: 10.1016/j.ancard.2017.10.015. Epub 2017 Oct 31. Review. French.

PMID:
29096905
4.

Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study.

van Geuns RJ, Sideris G, Van Royen N, El Mahmoud R, Diletti R, Bal Dit Sollier C, Garot J, Van Der Hoeven NW, Cortese B, Ding L, Lechthaler I, Deliargyris EN, Anthopoulos P, Drouet L.

EuroIntervention. 2017 Aug 4;13(5):e540-e548. doi: 10.4244/EIJ-D-17-00307.

5.

Enoxaparin chains stored during chronic treatment are mobilized by a bolus of unfractionated heparin: insights from the STACKENOX study.

Bal Dit Sollier C, Berge N, Drouet L.

Blood Coagul Fibrinolysis. 2016 Oct;27(7):779-785.

PMID:
26720847
6.

Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?

Drouet L, Bal Dit Sollier C, Steiner T, Purrucker J.

Int J Stroke. 2016 Oct;11(7):748-58. doi: 10.1177/1747493016659671. Epub 2016 Jul 13. Review.

PMID:
27412190
7.

Impaired biological response to aspirin in therapeutic hypothermia comatose patients resuscitated from out-of-hospital cardiac arrest.

Llitjos JF, Sideris G, Voicu S, Bal Dit Sollier C, Deye N, Megarbane B, Drouet L, Henry P, Dillinger JG.

Resuscitation. 2016 Aug;105:16-21. doi: 10.1016/j.resuscitation.2016.04.027. Epub 2016 May 17.

PMID:
27224446
8.

Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy.

Dillinger JG, Si Moussi T, Berge N, Bal Dit Sollier C, Henry P, Drouet L.

Thromb Res. 2016 Apr;140:66-72. doi: 10.1016/j.thromres.2016.02.006. Epub 2016 Feb 20.

PMID:
26901852
9.

[The anticoagulation clinics].

Bal dit Sollier C, Drouet L.

Rev Prat. 2015 Feb;65(2):202-3. French. No abstract available.

PMID:
25939223
10.

Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy.

Amsallem M, Manzo-Silberman S, Dillinger JG, Sideris G, Voicu S, Bal dit Sollier C, Drouet L, Henry P.

Am J Cardiol. 2015 May 1;115(9):1305-10. doi: 10.1016/j.amjcard.2015.02.012. Epub 2015 Feb 12.

PMID:
25759104
11.

Ticagrelor effectiveness overestimated by VASP index: platelet inhibition by ticagrelor versus prasugrel in acute coronary syndrome patients according to platelet function tests.

Dillinger JG, Manzo Silberman S, Bal dit Sollier C, Amsallem M, Sideris G, Voicu S, Henry P, Drouet L.

Int J Cardiol. 2014 Sep 20;176(2):557-9. doi: 10.1016/j.ijcard.2014.07.019. Epub 2014 Jul 12. No abstract available.

PMID:
25074556
12.

Absorption and efficacy of acetylsalicylic acid in patients with short bowel syndrome.

Faye E, Drouet L, De Raucourt E, Green A, Bal-Dit-Sollier C, Boudaoud L, Corcos O, Bergmann JF, Joly F, Lloret-Linares C.

Ann Pharmacother. 2014 Jun;48(6):705-10. doi: 10.1177/1060028014526700. Epub 2014 Mar 25.

PMID:
24667978
13.

Monitoring persistent platelet reactivity in patients with unprotected left main stenting.

Dillinger JG, Sideris G, Kchaou I, Bal Dit Sollier C, Manzo Silberman S, Voicu S, Magkoutis N, Logeart D, Drouet L, Henry P; ALMA (Angioplasty of Left Main - lAriboisiere) study.

J Interv Cardiol. 2013 Dec;26(6):578-85. doi: 10.1111/joic.12076. Epub 2013 Nov 13.

PMID:
24224796
14.

Validation of a live animal model for training in endoscopic hemostasis of upper gastrointestinal bleeding ulcers.

Camus M, Marteau P, Pocard M, Bal Dit Sollier C, Lavergne-Slove A, Thibault A, Lecleire S, Vienne A, Coffin B, Drouet L, Dray X.

Endoscopy. 2013 Jun;45(6):451-7. doi: 10.1055/s-0032-1326483. Epub 2013 Jun 3.

PMID:
23733728
15.

Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease.

Dillinger JG, Drissa A, Sideris G, Bal dit Sollier C, Voicu S, Manzo Silberman S, Logeart D, Drouet L, Henry P.

Am Heart J. 2012 Oct;164(4):600-606.e1. doi: 10.1016/j.ahj.2012.06.008.

PMID:
23067920
16.

In vivo effect of proton-pump inhibitors on gastric plasmin-dependent fibrinolysis: a study in a porcine model.

Thibault A, Marteau P, Drouet L, Lavergne Slove A, Bal dit Sollier C, Camus M, Dray X.

Dig Liver Dis. 2012 Dec;44(12):995-8. doi: 10.1016/j.dld.2012.06.017. Epub 2012 Aug 11.

PMID:
22890053
17.

Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocythemia.

Dillinger JG, Sideris G, Henry P, Bal dit Sollier C, Ronez E, Drouet L.

Thromb Res. 2012 Jan;129(1):91-4. doi: 10.1016/j.thromres.2011.09.017. Epub 2011 Oct 19. No abstract available.

PMID:
22014557
18.

FXIII-A Leu34 genetic variant in premature coronary artery disease: a genotype--phenotype case control study.

Silvain J, Pena A, Vignalou JB, Hulot JS, Galier S, Cayla G, Bellemain-Appaix A, Barthélémy O, Beygui F, Bal-dit-Sollier C, Drouet L, Weisel JW, Montalescot G, Collet JP.

Thromb Haemost. 2011 Sep;106(3):511-20. doi: 10.1160/TH11-01-0027. Epub 2011 Jul 28.

19.

[Antiplatelet agents and diabetes mellitus].

Drouet L, Bal dit Sollier C, Henry P.

Ann Cardiol Angeiol (Paris). 2010 Dec;59 Suppl 2:S56-64. doi: 10.1016/S0003-3928(10)70011-1. French.

PMID:
21237324
20.

Amoxicillin/clavulanic acid-warfarin drug interaction: a randomized controlled trial.

Zhang Q, Simoneau G, Verstuyft C, Drouet L, Bal dit Sollier C, Alvarez JC, Rizzo-Padoin N, Bergmann JF, Becquemont L, Mouly S.

Br J Clin Pharmacol. 2011 Feb;71(2):232-6. doi: 10.1111/j.1365-2125.2010.03824.x.

21.

Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial.

Zhang Q, Bal-dit-Sollier C, Drouet L, Simoneau G, Alvarez JC, Pruvot S, Aubourg R, Berge N, Bergmann JF, Mouly S, Mahé I.

Eur J Clin Pharmacol. 2011 Mar;67(3):309-14. doi: 10.1007/s00228-010-0975-2. Epub 2010 Dec 30.

PMID:
21191575
22.

24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease.

Henry P, Vermillet A, Boval B, Guyetand C, Petroni T, Dillinger JG, Sideris G, Bal dit Sollier C, Drouet L.

Thromb Haemost. 2011 Feb;105(2):336-44. doi: 10.1160/TH10-02-0082. Epub 2010 Dec 7.

PMID:
21136023
23.

[The basis of platelets: platelets and atherothrombosis: an understanding of the lack of efficacy of aspirin in peripheral arterial disease (PAD) and diabetic patients].

Drouet L, Bal dit Sollier C, Henry P.

Drugs. 2010 Nov 1;70 Suppl 1:9-14. doi: 10.2165/00000005-000000000-00000. Review. Japanese.

PMID:
20977287
24.

Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.

Bal Dit Sollier C, Berge N, Boval B, Dubar M, Drouet L.

Thromb Haemost. 2010 Sep;104(3):571-81. doi: 10.1160/TH09-11-0803. Epub 2010 Jul 20.

PMID:
20664906
25.

Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies.

Thim T, Hagensen MK, Drouet L, Bal Dit Sollier C, Bonneau M, Granada JF, Nielsen LB, Paaske WP, Bøtker HE, Falk E.

EuroIntervention. 2010 Jun;6(2):261-8. doi: 10.4244/.

PMID:
20562079
26.

Improving anticoagulation control in hospitalized elderly patients on warfarin.

Gouin-Thibault I, Levy C, Pautas E, Cambus JP, Drouet L, Mahé I, Bal Dit Sollier C, Horellou MH, Golmard JL, Siguret V.

J Am Geriatr Soc. 2010 Feb;58(2):242-7. doi: 10.1111/j.1532-5415.2009.02675.x. Epub 2010 Jan 26.

PMID:
20374400
27.

Slow response to clopidogrel predicts low response.

Bellemain-Appaix A, Montalescot G, Silvain J, Barthélémy O, Beygui F, Collet JP, Sideris G, Meuleman C, Bal-Dit-Sollier C, Lellouche N, Ducrocq G, Slama M, Milleron O, Henry P, Drouet L; ALBION Investigators.

J Am Coll Cardiol. 2010 Feb 23;55(8):815-22. doi: 10.1016/j.jacc.2009.08.082.

28.

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels.

Lavigne-Lissalde G, Sanchez C, Castelli C, Alonso S, Mazoyer E, Bal Dit Sollier C, Drouet L, Juhan-Vague I, Gris JC, Alessi MC, Morange PE.

J Thromb Haemost. 2010 May;8(5):942-9. doi: 10.1111/j.1538-7836.2010.03773.x. Epub 2010 Jan 22.

29.

Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study.

Montalescot G, Sideris G, Cohen R, Meuleman C, Bal dit Sollier C, Barthélémy O, Henry P, Lim P, Beygui F, Collet JP, Marshall D, Luo J, Petitjean H, Drouet L.

Thromb Haemost. 2010 Jan;103(1):213-23. doi: 10.1160/TH09-07-0482. Epub 2009 Oct 26.

PMID:
20062936
30.

Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets.

Chollet ME, Brouland JP, Bal dit Sollier C, Bauduer F, Drouet L, Bellucci S.

Br J Haematol. 2010 Mar;148(5):805-7. doi: 10.1111/j.1365-2141.2009.07989.x. Epub 2009 Dec 1. No abstract available.

PMID:
19958354
31.

Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke.

Bal Dit Sollier C, Crassard I, Simoneau G, Bergmann JF, Bousser MG, Drouet L.

Cerebrovasc Dis. 2009;28(5):505-13. doi: 10.1159/000236915. Epub 2009 Sep 12.

PMID:
19752552
32.
33.

Haplotypic or genotypic combinations of three protein Z polymorphisms influence protein Z plasma level.

Le Cam-Duchez V, Barbay V, Bal Dit Sollier C, Drouet L, Coudert M, Soria C, Borg JY.

Thromb Haemost. 2009 Jan;101(1):212-4. No abstract available.

PMID:
19132212
34.

Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy.

Bal Dit Sollier C, Berge N, Boval B, Hovsepian L, Drouet L.

Thromb Haemost. 2009 Jan;101(1):116-22.

PMID:
19132197
35.

[Monitoring of anticoagulant treatment in patients with cancer].

Mahé I, Bosquet A, Medjkane A, Bal dit Sollier C, Drouet L.

Pathol Biol (Paris). 2008 Jun;56(4):239-44. doi: 10.1016/j.patbio.2008.02.011. Epub 2008 Apr 14. French.

PMID:
18407438
36.

Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function: a comparative pharmacokinetic study.

Mahé I, Aghassarian M, Drouet L, Bal Dit-Sollier C, Lacut K, Heilmann JJ, Mottier D, Bergmann JF.

Thromb Haemost. 2007 Apr;97(4):581-6.

PMID:
17393021
37.

[Use and monitoring of vitamin K antagonists in everyday medical practice. French results of the international ISAM study of patients with nonvalvular atrial fibrillation].

Mahé I, Bal dit Sollier C, Duru G, Lamarque H, Bergmann JF, Drouet L.

Presse Med. 2006 Dec;35(12 Pt 1):1797-803. French.

PMID:
17159730
38.

Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study.

Mahé I, Bertrand N, Drouet L, Bal Dit Sollier C, Simoneau G, Mazoyer E, Caulin C, Bergmann JF.

Haematologica. 2006 Dec;91(12):1621-7.

39.

Relationship of circulating biomarkers of inflammation and hemostasis with preclinical atherosclerotic burden in nonsmoking hypercholesterolemic men.

Chironi G, Dosquet C, Del-Pino M, Denarie N, Megnien JL, Drouet L, Bal dit Sollier C, Levenson J, Simon A.

Am J Hypertens. 2006 Oct;19(10):1025-31.

PMID:
17027822
40.

A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial.

Montalescot G, Sideris G, Meuleman C, Bal-dit-Sollier C, Lellouche N, Steg PG, Slama M, Milleron O, Collet JP, Henry P, Beygui F, Drouet L; ALBION Trial Investigators.

J Am Coll Cardiol. 2006 Sep 5;48(5):931-8. Epub 2006 Aug 17.

41.

Wine constituents inhibit thrombosis but not atherogenesis in C57BL/6 apolipoprotein E-deficient mice.

Soulat T, Philippe C, Bal dit Sollier C, Brézillon C, Berge N, Teissedre PL, Callebert J, Rabot S, Drouet L.

Br J Nutr. 2006 Aug;96(2):290-8.

PMID:
16923223
42.

Quantitation of megakaryocytopoiesis by computerized automatic in culture image analysis.

Lecomte-Raclet L, Aidoudi S, Lebeurier I, Bal dit Sollier C, Kishtoo G, Aubert JF, Caen JP, Han ZC.

Platelets. 1998;9(2):121-7.

PMID:
16793687
43.
44.

[Is fibrinogen a predictor or a marker of the risk of cardiovascular events?].

Drouet L, Bal dit Sollier C.

Therapie. 2005 Mar-Apr;60(2):125-36. Review. French.

PMID:
15969315
45.

Lack of association between ADH3 polymorphism, alcohol intake, risk factors and carotid intima-media thickness.

Marques-Vidal P, Bal Dit Sollier C, Drouet L, Boccalon H, Ruidavets JB, Ferrières J.

Atherosclerosis. 2006 Feb;184(2):397-403. Epub 2005 Jun 6.

PMID:
15941567
46.

Paracetamol: a haemorrhagic risk factor in patients on warfarin.

Mahé I, Bertrand N, Drouet L, Simoneau G, Mazoyer E, Bal dit Sollier C, Caulin C, Bergmann JF.

Br J Clin Pharmacol. 2005 Mar;59(3):371-4.

47.

Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic events.

Drouet L, Bal Dit Sollier C.

Eur J Clin Invest. 2005 Mar;35 Suppl 1:21-6. Review.

PMID:
15701144
48.

CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis.

Amar J, Ruidavets JB, Bal dit Sollier C, Bongard V, Boccalon H, Chamontin B, Drouet L, Ferrières J.

J Hypertens. 2004 Aug;22(8):1523-8.

PMID:
15257175
49.

Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis.

Bal dit Sollier C, Kang C, Berge N, Herault JP, Bonneau M, Herbert JM, Drouet L.

J Thromb Haemost. 2004 Jun;2(6):925-30.

50.

Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness.

Amar J, Ruidavets JB, Bal Dit Sollier C, Bongard V, Boccalon H, Chamontin B, Drouet L, Ferrières J.

J Hypertens. 2004 Feb;22(2):349-55.

PMID:
15076193

Supplemental Content

Loading ...
Support Center